ENETs/INCA Patient Symposium March 2018

ENETs Sim 3 pic ENETs/INCA Patient Symposium March 2018

A Joint
Effort by NET Patient and Medical Leaders to Identify and Address Issues That
Impede Optimal Care and Research

We are so grateful to the ENETs advisory board who for the
second year supported the INCA/ENETs join patient symposium as part of the main
scientific meeting. The number of participants was a significant increase on
last year which indicated the importance of hearing from patients. The key
areas covered were addressing the “patient information gap”, how can we improve
the information that is being delivered to patients at time of diagnosis and
throughout their treatment journey, how to improve access to treatments such as
PRRT and how to involve patients in research from trial design to clinical
trials. As so clearly put by Dr Ben Lawrence ‘….we would not design a treatment
plan without consulting the patient, thus we should not design research without
including the patient…..’

Speakers and panelists included:

Prof Martyn Caplin (Royal Free Hospital UK)

Simone Leyden (INCA President)

Ron Hollander (Past President of INCA)

Teodora Kolarova (Executive Director of INCA)

Kate Wakelin (NET Nurse Unicorn Foundation Aus)

Dr Ben Lawrence (Auckland NZ)

Josh Mailman (USA)

Cathy Bouvier (NET Patient Foundation UK)

For the full program please click here and we
look forward to reporting back next year on how these issues have been
addressed.

ENETs SIm 2 pic   ENETs Kate 3     ENETs Kate speaking     ENETs Sim pic   ENETs Kate 2   slide1     slide2     Slide3   Slide4   Slide5   Slide6

Share this article

Subscribe to our Newsletter

Stay up to date on news and events, clinical trials and new research on neuroendocrine cancers.

Related News

Nurses Workshop, Sunday, 17 May 2026

Healing NETS Summit

PBAC recommendation for selpercatinib a step forward for patient access

Expressions of interest open for ANZSNM nurse and allied health workshop in Canberra

Tax Appeal

Screenshot 2026-05-20 at 2.12.07 PM

Help 31,000+ neuroendocrine cancer patients get the specialised care they deserve.

Every dollar raised is fully tax deductible and helps fund much needed advocacy efforts and patient support.